Pure red cell aplasia is a rare adverse event, which is characterized by anemia, low reticulocyte count, absence of erythroblasts, resistance to EPO, and neutralizing antibodies against EPO [58]. The gene discussed is EPO; the disease is pure red-cell aplasia.